These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2117285)

  • 1. Cyclic interferon gamma application in patients with renal cell carcinoma.
    Grups JW; Frohmüller HG
    Prog Clin Biol Res; 1990; 350():257-62. PubMed ID: 2117285
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor effects of interleukin 2 against renal cell carcinoma. In vitro study and clinical application.
    Marumo K; Tazaki H
    Prog Clin Biol Res; 1990; 350():263-73. PubMed ID: 2117286
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
    Debruyne FM; Franssen MP; Beniers AJ; Schalken JA; de Mulder PH
    Prog Clin Biol Res; 1990; 350():243-55. PubMed ID: 2117284
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferons in renal-cell carcinoma: status and prospects.
    De Mulder PH; Debruyne FM; Beniers AJ
    Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
    Bergerat JP; Ford J; Herbrecht R; Dufour P; Oberling F; Jacqmin D; Bollack C; Prevot G; Salze P; Jurascheck F
    Prog Clin Biol Res; 1990; 348():137-50. PubMed ID: 2385604
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant alpha-2 or gamma interferon in the treatment of metastatic renal cell carcinoma: results of two phase II/III trials.
    Otto U; Schneider AW; Conrad S; Klosterhalfen H
    Prog Clin Biol Res; 1990; 350():275-82. PubMed ID: 2117287
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer immunotherapy using tumor-infiltrating lymphocytes.
    Figlin RA
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):33-5. PubMed ID: 1535456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
    Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.
    Holdener EE; Emmons RP; Brunda M; Evans L; Levitt D
    Prog Clin Biol Res; 1990; 348():61-9. PubMed ID: 2201034
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
    Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
    Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological effect of recombinant interferon-gamma in renal cell carcinoma].
    Kawata N; Ono M; Endo M; Ichinose T; Hamada T; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1993 Jun; 39(6):511-5. PubMed ID: 8337976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].
    Hofmockel G; Wirth MP; Heimbach D; Frohmüller HG
    Urologe A; 1993 Jul; 32(4):290-4. PubMed ID: 8372410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial.
    Otto U; Conrad S; Schneider AW; Klosterhalfen H
    Arzneimittelforschung; 1988 Nov; 38(11):1658-60. PubMed ID: 3145743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
    Shirahama T; Kayajima T; Ohi Y
    In Vivo; 1989; 3(5):345-9. PubMed ID: 2519876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activation of LAK cells during systemic IL-2 therapy.
    Lang P; Vitté-Mony I; Farace F; Stancou R; Triebel F; Escudier B; Hercend T; Bertoglio J
    Eur Cytokine Netw; 1990; 1(3):185-8. PubMed ID: 2129800
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
    Gross AJ; Dieckmann KP; Krain J; Huland H
    Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of inhalant recombinant interferon-gamma in patients with pulmonary metastasis from renal tumor (preliminary report)].
    Kawata N; Takimoto Y; Hirakata H; Fuse T; Hirano D; Yamanaka Y
    Hinyokika Kiyo; 1994 Sep; 40(9):773-6. PubMed ID: 7801837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and pharmacokinetics of continuous subcutaneous infusion of low-dose interferon-gamma: a pilot study.
    Satake I; Tari K; Nakagomi K; Ozawa K
    Jpn J Clin Oncol; 1993 Dec; 23(6):356-62. PubMed ID: 8283789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.